Form D Explorer

Inspect source fieldsReport a record issue

Form D — KIORA PHARMACEUTICALS INC

0001372514-26-000038 · filed Apr 21, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$5,000,000
Reported amount sold
$5,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
KIORA PHARMACEUTICALS INC
CIK
1372514
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
169 SAXONY RD.
ENCINITAS, California 92024
Phone
858-224-9600

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗